...strategies, including small-molecule treatments and marker-based 32 selection, are constrained by cytotoxicity, genomic scarring, and inconsistent 33 performance. Here, we present ESS-HDR (essential gene–supported scarless HDR), a 34 robust, drug- and marker-free platform that selectively enriches HDR...